MichBio Member News

Accuri Cytometers, Inc., and eBioscience, the number two supplier of research flow cytometry reagents, announced that they have entered into a worldwide co-marketing agreement. The collaboration is designed to offer scientists a better and more comprehensive solution for their flow cytometry research needs, harnessing the cost-effectiveness, ease-of-use, performance capabilities and accessibility of the Accuri C6 Flow Cytometer® System with the market leading extensive line of high quality cytometer research reagents offered by eBioscience.

Michigan State University College of Human Medicine and MidMichigan Health have agreed to establish a new regional medical campus in Midland.

MSU officials say the partnership is the result of shared goals to educate medical students within a health care system that values quality and provides care to a widely dispersed city and rural community.

Accuri Cytometers Inc., a life sciences company manufacturing and marketing revolutionary bench-top flow cytometer systems, today announced the sale of the 500th unit of its Accuri C6 Flow Cytometer® System and the 2010 recipients of its Accuri Cytometers Creativity Awards program, which provides a free Accuri C6 Flow Cytometer to researchers in the U.S. and Europe who design highly innovative uses of flow cytometry.

Plex Systems, Inc., provider of the No. 1 rated manufacturing ERP software, Plex Online, today announced that it achieved recurring revenue growth of 28 percent in the first quarter 2010 compared with the same quarter in 2009. Total revenues grew 18 percent quarter over quarter.

The company also added eight new customers and continued to receive industry recognition.

A compound derived from broccoli could help prevent or treat breast cancer by targeting cancer stem cells -- the small number of cells that fuel a tumor's growth -- according to a new study from researchers at the University of Michigan Comprehensive Cancer Center.
Broccoli component limits breast cancer stem cells, U-M study finds

The study tested sulforaphane, a component of broccoli and broccoli sprouts, in both mice and cell cultures. Researchers found sulforaphane targeted and killed the cancer stem cells and prevented new tumors from growing.

Asterand plc, a leading provider of human tissue and human tissue-based services to pharmaceutical and biotechnology companies engaged in drug discovery, announced that its subsidiary BioSeek, LLC, a pioneer in the application of predictive human biology to drug discovery, has signed a two-year collaboration agreement with Eisai Co., Ltd., a research-based human health care company headquartered in Japan.

Nancy Kreis Newman has joined Vestaron Corporation as vice president of finance and chief financial officer.  Previously, Newman was chief financial officer with A.M. Todd Group, Inc., a manufacturer of essential oils, flavor compounds and botanical extracts, located in Kalamazoo.

Significant Progress Made in Advancing Company’s Small Molecules for the Treatment of Autoimmune Diseases; Appoints Chairman of the Board and Welcomes New Vice President in Preparation for Clinic

Levels of a key type of immune cell are higher in head and neck cancer patients whose tumors are linked to the human papillomavirus, or HPV, according to researchers at the University of Michigan Comprehensive Cancer Center.

The finding suggests a way to predict which tumors are most likely to respond to chemotherapy and radiation and allow doctors to choose the best treatment option up front.